Necrotizing fasciitis and myositis caused by streptococcal flesh-eating bacteria

Journal of Clinical Rheumatology

Volumn 16, Issue 8, 2010, Pages 382-384

  Garcia Casares E ^a   Mateo Soria, L ^a   Garcia Melchor E ^a   Riera Alonso, E ^a   Olive Marques A ^a   Holgado Perez S ^a   Tena Marsa X ^a   Molinos Abos S ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

location; management; myositis; streptococcal necrotizing fasciitis

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; IMMUNOGLOBULIN; PENICILLIN G;

ADULT; AGED; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DEBRIDEMENT; ECHOCARDIOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOCOMPROMISED PATIENT; KIDNEY TRANSPLANTATION; LABORATORY TEST; MALE; MYOSITIS; NECROTIZING FASCIITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STAPHYLOCOCCUS INTERMEDIUS; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; TISSUE CULTURE;

AGED; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DEBRIDEMENT; DRUG THERAPY, COMBINATION; FASCIITIS, NECROTIZING; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; MYOSITIS; PENICILLINS; STREPTOCOCCUS PYOGENES; TREATMENT OUTCOME;

EID: 78650415277     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181fe8ba3     Document Type: Article

References (19)

1. Kaul R, McGeer A, Low DE, et al. Population-based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med. 1997;103:18-24.
2. Forni AL, Kaplan EL, Schlievert PM, et al. Clinical and microbiological characteristics of severe group A streptococcus infections and streptococcal toxic shock syndrome. Clin Infect Dis. 1995;21:333-340.
3. Stevens DL, Bryant AL, Hackett SP. Group A streptococcal bacteremia: the role of tumor necrosis factor in shock or organ failure. J Infect Dis. 1996;173:619-626.
4. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med. 1989;321:1-6.
5. Golger A, Ching S, Goldsmith CH, et al. Mortality in patients with necrotizing fasciitis. Plast Reconstr Surg. 2007;119:1803-1807.
6. Greene CM, Van Beneden CA, Javadi M, et al. Cluster of deaths from serogroup A streptococcus in a long-term care facilityVGeorgia, 2001. Am J Infect Control. 2005;33:108-113.
7. Tang WM, Wong JWK, Wong LLS, et al. Streptococcal necrotizing myositis: the role of magnetic resonance imaging. J Bone Joint Surg. 2001;83:1723-1725.
8. Wong CH, Chang HC, Pausapathy S, et al. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am. 2003;85:1454-1460.
9. Sierra JM, Sánchez F, Castro P, et al. Group A streptococcal infections in injection drug users in Barcelona, Spain: epidemiologic, clinical, and microbiologic análisis of 3 clusters of cases from 2000 to 2003. Medicine (Baltimore). 2006;85:139-146.
10. Kamran M, Wachs J, Putterman C. Necrotizing fasciitis in systemic lupus erythematosus. Semin Arthritis Rheum. 2008;37:236-242.
11. Yu KH, Ho HH, Chen JY, et al. Gout complicated with necrotizing fasciitisYreport of 15 cases [published online ahead of print January 13, 2004]. Rheumatology (Oxford). 2004;43:518-521.
12. Chikkamuniyappa S. Streptococcal toxic shock syndrome and sepsis manifesting in a patient with chronic rheumatoid arthritis. Dermatol Online J. 2004;10:7.
13. Chan AT, Cleeve V, Daymond TJ. Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis. Postgrad Med J. 2002;78:47-48.
14. Rieger UM, Gugger CY, Farhadi J, et al. Prognostic factors in necrotizing fasciitis and myositis: analysis of 16 consecutive cases at a single institution in Switzerland. Ann Plast Surg. 2007;58:523-530.
15. Weiss KA, Laverdiere M. Group A streptococcus invasive infections: a review. Can J Surg. 1997;40:18-25.
16. Mulla ZD, Leaverton PE, Wiersma ST. Invasive group A streptococcal infections in Florida. South Med J. 2003;96:968-973.
17. Stevens DL, Gibbons AE, Bergstrom R, et al. The Eagle effect revisited: efficacy of clindamycin, erythromycin and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988;158:23-28.
18. Norrby-Teglund A, Muller MP, Mcgeer A, et al. Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach. Scand J Infect Dis. 2005;37:166-172.
19. Edlich RF, Cross CL, Dahlstrom JJ, et al. Modern concepts of the diagnosis and treatment of necrotizing fasciitis. J Emerg Med. 2010;39:261-265. Epub 2008 Dec 11.